Telemedicine

Validic Review for Telehealth CEOs (2025)

Clock Icon - Consultant Webflow Template

Validic Review for Telehealth CEOs: The API Powerhouse for Remote Patient Monitoring

Introduction: Why RPM Is No Longer Optional

Telehealth is shifting from transactional visits → continuous care. Investors, payers, and boards all demand proof of outcomes, adherence, and retention.

👉 That’s where Remote Patient Monitoring (RPM) comes in. It’s the connective tissue that links devices, wearables, and patient data into your care model.

Validic is one of the most recognized RPM platforms, focused on data aggregation + API integration. Unlike turnkey kits (Optimize Health, 100Plus), Validic empowers telehealth companies to build their own device-driven engagement flywheel.

Section 1: What Is Validic?

  • Overview: A digital health platform that integrates wearable/device data (glucose monitors, BP cuffs, scales, fitness trackers) into telehealth/EHR workflows.
  • Target Market: Telehealth platforms, health systems, payers, and MedTech companies.
  • Differentiator: API-first → connects 500+ devices + apps, normalizes data, delivers it into EHR/analytics.

Section 2: Compliance Check

  • HIPAA: ✅ BAA included; PHI encryption.
  • FDA: Not a device manufacturer — a data integration platform.
  • GDPR: ✅ International compliance supported.

CEO takeaway: Investor-friendly because it avoids FDA device liability, focusing instead on data enablement.

Section 3: Strengths

  1. Massive Device Ecosystem
    • 500+ connected devices + apps (Fitbit, Apple Health, Dexcom, Omron, Withings).
    • Avoids vendor lock-in → future-proof.
  2. API-First Architecture
    • Fits into telehealth platforms, EHRs, analytics stacks.
    • Normalizes messy device data → actionable insights.
  3. Scalable for Growth
    • Used by health systems + national payers.
    • Proves diligence-safe for PE/VC.
  4. Enables Outcomes Data
    • RPM metrics → strengthens contracts, valuation multiple.
    • Turns “visits” into “continuous engagement.”

Section 4: Weaknesses

  1. Not Turnkey
    • Requires dev resources to integrate.
    • Not plug-and-play for early startups.
  2. No Patient Kit Logistics
    • Unlike Optimize/100Plus, doesn’t ship devices.
    • You handle sourcing, training, logistics.
  3. Cost
    • Enterprise pricing model, not SMB-friendly.

Section 5: Integrations

  • EHRs: Epic, Athenahealth, Elation, DrChrono.
  • Analytics: Freshpaint, Segment HIPAA, Piwik Pro.
  • Devices: Continuous glucose monitors, BP cuffs, scales, wearables.

CEO Tip: Pair Validic with your analytics stack to turn RPM into board-ready outcomes reporting.

Section 6: Pricing Model

  • Enterprise licensing based on volume + integration scope.
  • Custom contracts — not transparent SMB pricing.

Unit Economics Impact:

  • High upfront cost.
  • Justifiable if tied to payer contracts or outcome-based reimbursement.

Section 7: Best Fit For

  • Growth-stage telehealth ($10M+ ARR).
  • MedTech companies needing device data integration.
  • Telehealth scaling into payer/employer contracts.

Not ideal for:

  • MVP-stage telehealth (too heavy).
  • Clinics needing plug-and-play kits.

Section 8: Alternatives to Validic

  • Optimize Health → Turnkey RPM kits for providers.
  • 100Plus → Simplified RPM kits for SMB practices.
  • Dexcom/Abbott APIs → Device-specific, not aggregated.

👉 Related posts: [Optimize Health Review] | [100Plus Review]

Section 9: CEO / Investor Lens

Fragile story:

“We plan to add wearables later, but nothing integrated yet.”
  • Investors hear: weak outcomes, fragile contracts.

Defensible story:

“We use Validic to integrate 500+ devices into our EHR + analytics stack. This delivers continuous outcomes data to payers and drives higher retention.”
  • Investors hear: outcomes moat, valuation-safe.

Section 10: Verdict

Strengths: API-first, huge device ecosystem, scalable, investor credibility.

Weaknesses: No turnkey kits, dev-heavy, enterprise pricing.

Bottom line:

  • Best for growth-stage telehealth/MedTech scaling into outcomes-driven contracts.
  • Not for MVP-stage startups needing fast RPM deployment.

CTA: Why RPM = Valuation Multiplier

Boards and payers want proof of outcomes. Validic turns devices into a valuation moat.

That’s why I built the Growth Clarity Diagnostic™.

In one session, we’ll:

  • Audit your RPM strategy.
  • Map integration gaps.
  • Build an investor-ready outcomes roadmap.

👉 [Book your Growth Clarity Diagnostic™ here.]

Because in telehealth, RPM = valuation multiplier.

FAQ

Is Validic HIPAA compliant?

Yes, with BAAs.

Does Validic ship devices?

No — it integrates data from devices you source.

Is Validic investor-ready?

Yes, especially for payer/employer contracts.

What’s Validic’s biggest strength?

API-first aggregation of 500+ devices + apps.

What’s Validic’s biggest weakness?

Not turnkey → requires dev + logistics on your side.

Charles Kirkland

Fractional CMO for Health and MedTech Brands

Fractional CMO leadership to grow $3M–$30M brands with precision, compliance, and profit. I specialize in FDA-regulated devices, telehealth, DTC, and platform-based health offers.